Overview: Luxturna by Spark Therapeutics 

Overview: Luxturna by Spark Therapeutics 

Slides in the pack:

1. Gene therapies and LUXTURNA
2. Current status of LUXTURNA
3. Development timeline: LUXTURNA
4. Epidemiology and market opportunity for LUXTURNA
5. Steps involved in manufacturing LUXTURNA
6. Phase III trial protocol with LUXTURNA
7. Safety with LUXTURNA
8. Spark Therapeutics: clinical development pipeline
9. Replacement gene  therapies in development